Every $1 spent on technological innovations in heart attack care has produced an estimated $7 gain.
[ Get More Details ]
“Increasing life expectancy in western society is a result of two major success stories in the prevention and treatment of human disease. The first milestone was eliminating the scourge of… [ Get More Details ]
Over the past 15 years, three classes of drugs have reduced mortality and improved symptoms of heart failure in patients who have decreased heart muscle function. These classes of drugs… [ Get More Details ]
Cost-savings associated with optimal anticoagulation in AFib patients
If half of all atrial fibrillation patients receiving suboptimal or no anticoagulation instead received optimal anticoagulation, 28,000 strokes could be prevented each year at a savings of around $2.5 billion in direct… [ Get More Details ]